Oxygenta Pharmaceutical Limited (BOM:524636)
India · Delayed Price · Currency is INR 108.45
-4.50 (-3.98%)
At close: Jul 14, 2025
Oxygenta Pharmaceutical Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 1.22 | 0.02 | 0.18 | 0.72 | 3.65 | Upgrade |
Short-Term Investments | - | 0.99 | 0.89 | 0.84 | 0.8 | Upgrade |
Cash & Short-Term Investments | 1.22 | 1.01 | 1.06 | 1.56 | 4.45 | Upgrade |
Cash Growth | 20.83% | -5.08% | -31.78% | -65.02% | 276.12% | Upgrade |
Accounts Receivable | 50.98 | 73.61 | 101.6 | 15.76 | 16.1 | Upgrade |
Receivables | 50.98 | 73.61 | 101.6 | 15.76 | 16.49 | Upgrade |
Inventory | 205.13 | 137.17 | 117.05 | 72.83 | 121.14 | Upgrade |
Prepaid Expenses | - | 0.4 | 0.24 | 0.11 | 0.51 | Upgrade |
Other Current Assets | 52.1 | 28.88 | 30.11 | 5.38 | 16.85 | Upgrade |
Total Current Assets | 309.43 | 241.06 | 250.06 | 95.64 | 159.44 | Upgrade |
Property, Plant & Equipment | 370.65 | 293.58 | 279.13 | 203.2 | 169.66 | Upgrade |
Long-Term Investments | 0.49 | 0.49 | 0.49 | 0.49 | 0.49 | Upgrade |
Long-Term Accounts Receivable | 10.83 | - | 3.97 | 3.68 | 2.19 | Upgrade |
Long-Term Deferred Tax Assets | 129.83 | 87.33 | - | - | - | Upgrade |
Other Long-Term Assets | 6.81 | 5.26 | 4.79 | 4.55 | 3.4 | Upgrade |
Total Assets | 828.04 | 631.92 | 542.65 | 311.76 | 338.65 | Upgrade |
Accounts Payable | 297.94 | 228.87 | 237.8 | 64.59 | 137.89 | Upgrade |
Accrued Expenses | - | 19.13 | 33.78 | 5.23 | 8.58 | Upgrade |
Short-Term Debt | - | 74.63 | 49.71 | 10.86 | 28.5 | Upgrade |
Current Portion of Long-Term Debt | 407.1 | 7.69 | 7.7 | - | - | Upgrade |
Other Current Liabilities | 153.44 | 6.62 | - | - | - | Upgrade |
Total Current Liabilities | 858.47 | 336.95 | 328.98 | 80.68 | 174.97 | Upgrade |
Long-Term Debt | 215.22 | 490.02 | 622.53 | 510.43 | 450.38 | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | 16.59 | 14.61 | 13.4 | Upgrade |
Other Long-Term Liabilities | 10.75 | 1.38 | 32.47 | 49.41 | 76.29 | Upgrade |
Total Liabilities | 1,084 | 833.15 | 1,005 | 658.05 | 718.83 | Upgrade |
Common Stock | 369.84 | 334.84 | 142.01 | 142.01 | 102.01 | Upgrade |
Additional Paid-In Capital | - | 96.41 | - | - | - | Upgrade |
Retained Earnings | - | -638.81 | -604.01 | -488.3 | -482.2 | Upgrade |
Comprehensive Income & Other | -626.24 | 6.34 | - | - | - | Upgrade |
Shareholders' Equity | -256.41 | -201.22 | -462 | -346.29 | -380.19 | Upgrade |
Total Liabilities & Equity | 828.04 | 631.92 | 542.65 | 311.76 | 338.65 | Upgrade |
Total Debt | 622.32 | 572.34 | 679.94 | 521.29 | 478.87 | Upgrade |
Net Cash (Debt) | -621.11 | -571.33 | -678.87 | -519.73 | -474.42 | Upgrade |
Net Cash Per Share | -17.25 | -17.83 | -47.80 | -40.78 | -37.23 | Upgrade |
Filing Date Shares Outstanding | 35.88 | 33.48 | 14.2 | 14.2 | 14.2 | Upgrade |
Total Common Shares Outstanding | 35.88 | 33.48 | 14.2 | 14.2 | 10.2 | Upgrade |
Working Capital | -549.05 | -95.89 | -78.92 | 14.96 | -15.53 | Upgrade |
Book Value Per Share | -7.15 | -6.01 | -32.53 | -24.38 | -37.27 | Upgrade |
Tangible Book Value | -256.41 | -201.22 | -462 | -346.29 | -380.19 | Upgrade |
Tangible Book Value Per Share | -7.15 | -6.01 | -32.53 | -24.38 | -37.27 | Upgrade |
Land | - | 1.82 | 1.82 | 1.82 | 1.82 | Upgrade |
Buildings | - | 78.45 | 70.43 | 57.66 | 42.68 | Upgrade |
Machinery | - | 425.07 | 392.04 | 304.93 | 267.34 | Upgrade |
Construction In Progress | - | - | - | 3.43 | 6.55 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.